Plaque morphology assessed by optical coherence tomography in the culprit lesions of the first episode of acute myocardial infarction in patients with low low-density lipoprotein cholesterol level.


Journal

Journal of cardiology
ISSN: 1876-4738
Titre abrégé: J Cardiol
Pays: Netherlands
ID NLM: 8804703

Informations de publication

Date de publication:
05 2020
Historique:
received: 12 09 2019
revised: 17 12 2019
accepted: 04 01 2020
pubmed: 23 2 2020
medline: 20 4 2021
entrez: 23 2 2020
Statut: ppublish

Résumé

There remains a residual risk for acute myocardial infarction (AMI) even with low low-density lipoprotein cholesterol (LDL-C) levels. This study aimed to characterize the culprit lesion morphology of AMI by optical coherence tomography (OCT) in patients with low LDL-C. Four-hundred and nine culprit lesions of 409 patients with their first presentation of AMI imaged by OCT were investigated. OCT analysis included the presence of plaque rupture and thin-capped fibroatheroma (TCFA). Fibrous cap thickness and lipid length were also measured. Intravascular ultrasound (IVUS) was performed in 368 (90.0%) patients. OCT and IVUS findings were compared between patients with LDL-C < 100 mg/dl (lower-LDL group) and those with LDL ≥ 100 mg/dl (higher-LDL group). Lower-LDL group included 93 (22.7%) patients. Plaque rupture (54.8% vs. 68.7%, p = 0.018) and TCFA (39.8% vs. 54.6%, p = 0.013) were less frequently observed in lower-LDL than in higher-LDL. Fibrous cap was thicker [73 (59-109) µm vs. 63 (57-83) µm, p = 0.028] and lipid length was smaller [5.4 (2.3-9.9) mm vs. 7.1 (4.1-10.5) mm, p = 0.012] in lower-LDL than in higher-LDL. There were no significant differences in IVUS parameters including plaque burden or remodeling index between the two groups. Patients with lower LDL-C showed more prevalent intact fibrous cap and less vulnerable features in the culprit lesions, which may suggest the need for exploring a specific strategy for the prevention of plaque erosion in low LDL-C subjects.

Sections du résumé

BACKGROUND
There remains a residual risk for acute myocardial infarction (AMI) even with low low-density lipoprotein cholesterol (LDL-C) levels. This study aimed to characterize the culprit lesion morphology of AMI by optical coherence tomography (OCT) in patients with low LDL-C.
METHODS
Four-hundred and nine culprit lesions of 409 patients with their first presentation of AMI imaged by OCT were investigated. OCT analysis included the presence of plaque rupture and thin-capped fibroatheroma (TCFA). Fibrous cap thickness and lipid length were also measured. Intravascular ultrasound (IVUS) was performed in 368 (90.0%) patients. OCT and IVUS findings were compared between patients with LDL-C < 100 mg/dl (lower-LDL group) and those with LDL ≥ 100 mg/dl (higher-LDL group).
RESULTS
Lower-LDL group included 93 (22.7%) patients. Plaque rupture (54.8% vs. 68.7%, p = 0.018) and TCFA (39.8% vs. 54.6%, p = 0.013) were less frequently observed in lower-LDL than in higher-LDL. Fibrous cap was thicker [73 (59-109) µm vs. 63 (57-83) µm, p = 0.028] and lipid length was smaller [5.4 (2.3-9.9) mm vs. 7.1 (4.1-10.5) mm, p = 0.012] in lower-LDL than in higher-LDL. There were no significant differences in IVUS parameters including plaque burden or remodeling index between the two groups.
CONCLUSIONS
Patients with lower LDL-C showed more prevalent intact fibrous cap and less vulnerable features in the culprit lesions, which may suggest the need for exploring a specific strategy for the prevention of plaque erosion in low LDL-C subjects.

Identifiants

pubmed: 32085904
pii: S0914-5087(20)30012-5
doi: 10.1016/j.jjcc.2020.01.001
pii:
doi:

Substances chimiques

Lipoproteins, LDL 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

485-493

Informations de copyright

Copyright © 2020 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.

Auteurs

Taishi Yonetsu (T)

Department of Interventional Cardiology, Tokyo Medical and Dental University, Tokyo, Japan; Department of Cardiovascular Medicine, Tokyo Medical and Dental University, Tokyo, Japan. Electronic address: t-yonetsu.cvm@tmd.ac.jp.

Masahiro Hoshino (M)

Department of Cardiovascular Medicine, Tsuchiura Kyodo General Hospital, Ibaraki, Japan.

Tetsumin Lee (T)

Department of Interventional Cardiology, Tokyo Medical and Dental University, Tokyo, Japan; Department of Cardiovascular Medicine, Tokyo Medical and Dental University, Tokyo, Japan.

Yoshihisa Kanaji (Y)

Department of Cardiovascular Medicine, Tsuchiura Kyodo General Hospital, Ibaraki, Japan.

Masao Yamaguchi (M)

Department of Cardiovascular Medicine, Tsuchiura Kyodo General Hospital, Ibaraki, Japan.

Masahiro Hada (M)

Department of Cardiovascular Medicine, Tsuchiura Kyodo General Hospital, Ibaraki, Japan.

Yohei Sumino (Y)

Department of Cardiovascular Medicine, Tsuchiura Kyodo General Hospital, Ibaraki, Japan.

Hiroaki Ohya (H)

Department of Cardiovascular Medicine, Tsuchiura Kyodo General Hospital, Ibaraki, Japan.

Yoshinori Kanno (Y)

Department of Cardiovascular Medicine, Tsuchiura Kyodo General Hospital, Ibaraki, Japan.

Hidenori Hirano (H)

Department of Cardiovascular Medicine, Tsuchiura Kyodo General Hospital, Ibaraki, Japan.

Tomoki Horie (T)

Department of Cardiovascular Medicine, Tsuchiura Kyodo General Hospital, Ibaraki, Japan.

Takayuki Niida (T)

Department of Cardiovascular Medicine, Tokyo Medical and Dental University, Tokyo, Japan.

Junji Matsuda (J)

Department of Cardiovascular Medicine, Tokyo Medical and Dental University, Tokyo, Japan.

Tomoyuki Umemoto (T)

Department of Cardiovascular Medicine, Tokyo Medical and Dental University, Tokyo, Japan.

Taro Sasaoka (T)

Department of Cardiovascular Medicine, Tokyo Medical and Dental University, Tokyo, Japan.

Yu Hatano (Y)

Department of Cardiovascular Medicine, Tokyo Medical and Dental University, Tokyo, Japan.

Tomoyo Sugiyama (T)

Department of Cardiovascular Medicine, Tsuchiura Kyodo General Hospital, Ibaraki, Japan.

Tetsuo Sasano (T)

Department of Cardiovascular Medicine, Tokyo Medical and Dental University, Tokyo, Japan.

Tsunekazu Kakuta (T)

Department of Cardiovascular Medicine, Tsuchiura Kyodo General Hospital, Ibaraki, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH